Hematology Advisor

Latest

Geriatric Assessment Instruments Underutilized Among Community Oncologists, Hematologists

Promising, Early Results for Combined HDAC and mTOR Inhibition in Relapsed/Refractory Hodgkin Lymphoma

Employment Disruption-Linked Financial Hardship Found for Female CA Survivors

Modern Radiation Therapy Limits Radiation Doses to Organs at Risk in Hodgkin Lymphoma

Prevalence, Recovery of Anemia in Hospitalized Patients With Critical Illness

Keytruda Approval Expands Classical Hodgkin Lymphoma Indication

Brentuximab Vedotin Plus Nivolumab as Chemotherapy-Free Strategy for Hodgkin Lymphoma in Older Patients

COVID-19–Free Surgical Pathways Benefit Patients Undergoing Elective Cancer Surgery

Underrepresentation of Women in Clinical Trials Persists

Case Report Details COVID-19 Reinfection in Immunocompromised Patient

Chemotherapy for Relapsed or Refracted Acute Myeloid Leukemia Unresponsive Venetoclax Salvage Therapy

First-line Therapy Response vs Switching Treatments in Chronic Myeloid Leukemia

Relationship Explored Between Physical Activity and Lymphoma

A doctor sits at his desk, working hard.

Leukemia

British Society for Haematology Guideline Update for the Diagnosis and Management of Chronic Myeloid Leukemia

The British Society for Haematology has published updated guidelines for the diagnosis and management of chronic myeloid leukemia in adults and children.

Lymphoma

Maternal, Fetal Considerations for the Treatment and Management of Lymphoma During Pregnancy

Although 1 in 1000 lymphoma diagnoses occurs in pregnancy, literature on best practices for treatment in this patient group is limited.

General Hematology

Most Coronavirus-Positive Cancer Patients Are Asymptomatic, Says Study

An analysis showed that outcomes of SARS-CoV-2 infections can be disproportionately mild in some patient cohorts.

Thrombotic Disorders

Thrombotic Thrombocytopenic Purpura: Expert Recommendations, Good Practice Statements for Critical Care

TTP is a rare disease that clinicians may not often treat; however, it is important to be aware of new developments for the treatment of this patient population.